Lily Dara MD
Hepatology & Liver Transplantation
Assistant Professor of Medicine, Keck School of Medicine, USC
Join to View Full Profile
1520 San Pablo StSte 1000Los Angeles, CA 90033
Phone+1 323-442-5100
Dr. Dara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lily Dara is a gastroenterologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC, USC Norris Comprehensive Cancer Center, and LAC+USC Medical Center. She received her medical degree from Shahid Beheshti University of Medical Sciences and has been in practice 13 years. She specializes in gastroenterology and hepatology and is experienced in cirrhosis and complications of portal hypertension, autoimmune liver diseases (autoimmune hepatitis and PBC), drug induced liver injury and hepatotoxicity, alcohol-associated liver disease, fatty liver disease, metabolic liver diseases, viral liver disease, liver disease in pregnancy, liver transplant, endoscopy, colonoscopy among others. She has more than 20 publications and over 500 citings. Her research focuses on hepatotoxicity and autoimmune liver diseases.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gastroenterology, 2010 - 2013
Griffin HospitalResidency, Internal Medicine, 2006 - 2010
Shahid Beheshti University of Medical SciencesClass of 2004
Certifications & Licensure
CA State Medical License 2009 - 2027
CT State Medical License 2009 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Immune-Mediated Liver Injury From Checkpoint Inhibitor: An Evolving Frontier With Emerging Challenges.Lily Dara, Eleonora De Martin
Liver International. 2025-02-01 - 1 citationsGenetic variants associated with immune-mediated liver injury from checkpoint inhibitors.Robert J Fontana, Yi-Ju Li, Vincent Chen, David Kleiner, Andrew Stolz
Hepatology Communications. 2024-09-01 - 2 citationsEvaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer.Robert Hsu, Batul Al-Zubeidy, Daniel Flores, Ari Nazarian, Aaron Baugh
Breast Cancer Research and Treatment. 2024-07-01
Grant Support
- Targeting Cell Death Pathways in Immune-mediated Liver Injury from Checkpoint InhibitorsUNIVERSITY OF SOUTHERN CALIFORNIA2022–2025
Professional Memberships
- AASLDMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
